OneShot Renal Denervation Registry

Last updated: August 31, 2015
Sponsor: Medtronic Endovascular
Overall Status: Terminated

Phase

2/3

Condition

Diabetes Prevention

Sleep Disorders

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT01844037
CP1002
  • Ages > 18
  • All Genders

Study Summary

This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient is an acceptable candidate for renal denervation based upon the Instructionsfor Use.

  • Patient is ≥ 18 years old.

  • Patient provided written informed consent.

Exclusion

Exclusion Criteria:

  • Patients who are pregnant, nursing, or planning to become pregnant.

  • Patients who have only one functioning kidney.

  • Allergy to contrast or known hypersensitivity to device materials

  • Patients with renal arteries < 4 mm in diameter.

  • Patients whose life expectancy is less than the planned period of study involvement.

Study Design

Total Participants: 51
Study Start date:
July 01, 2014
Estimated Completion Date:
March 31, 2015

Connect with a study center

  • Hospital San Raffaele

    Milano,
    Italy

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.